Zhang J, Guan X, Kong M, Xia M, et al. GLP-1RAs and tirzepatide may reduce heart failure risk in obese but not in non-obese patients with cardiovascular or renal disease: A systematic review and meta-analysis. Metabolism 2026;175:156433.
PMID: 41207615